NM_001135629.3:c.243T>C

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6BP7BA1

The NM_001135629.3(PPP1R21):​c.243T>C​(p.Ala81Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00389 in 1,614,020 control chromosomes in the GnomAD database, including 166 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).

Frequency

Genomes: 𝑓 0.019 ( 82 hom., cov: 32)
Exomes 𝑓: 0.0023 ( 84 hom. )

Consequence

PPP1R21
NM_001135629.3 synonymous

Scores

2

Clinical Significance

Benign no assertion criteria provided B:1

Conservation

PhyloP100: -0.238

Publications

0 publications found
Variant links:
Genes affected
PPP1R21 (HGNC:30595): (protein phosphatase 1 regulatory subunit 21) Located in early endosome. [provided by Alliance of Genome Resources, Apr 2022]
PPP1R21 Gene-Disease associations (from GenCC):
  • neurodevelopmental disorder with hypotonia, facial dysmorphism, and brain abnormalities
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant 2-48454711-T-C is Benign according to our data. Variant chr2-48454711-T-C is described in ClinVar as [Benign]. Clinvar id is 3038850.Status of the report is no_assertion_criteria_provided, 0 stars.
BP7
Synonymous conserved (PhyloP=-0.238 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0627 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PPP1R21NM_001135629.3 linkc.243T>C p.Ala81Ala synonymous_variant Exon 3 of 22 ENST00000294952.13 NP_001129101.1 Q6ZMI0-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PPP1R21ENST00000294952.13 linkc.243T>C p.Ala81Ala synonymous_variant Exon 3 of 22 1 NM_001135629.3 ENSP00000294952.8 Q6ZMI0-1

Frequencies

GnomAD3 genomes
AF:
0.0195
AC:
2959
AN:
152100
Hom.:
82
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0647
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0127
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00559
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000323
Gnomad OTH
AF:
0.0182
GnomAD2 exomes
AF:
0.00574
AC:
1444
AN:
251394
AF XY:
0.00456
show subpopulations
Gnomad AFR exome
AF:
0.0664
Gnomad AMR exome
AF:
0.00443
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000361
Gnomad OTH exome
AF:
0.00391
GnomAD4 exome
AF:
0.00227
AC:
3312
AN:
1461804
Hom.:
84
Cov.:
31
AF XY:
0.00218
AC XY:
1582
AN XY:
727206
show subpopulations
African (AFR)
AF:
0.0648
AC:
2168
AN:
33466
American (AMR)
AF:
0.00521
AC:
233
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39696
South Asian (SAS)
AF:
0.00514
AC:
443
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53414
Middle Eastern (MID)
AF:
0.00399
AC:
23
AN:
5768
European-Non Finnish (NFE)
AF:
0.000148
AC:
165
AN:
1111954
Other (OTH)
AF:
0.00464
AC:
280
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
174
348
523
697
871
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
76
152
228
304
380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0195
AC:
2968
AN:
152216
Hom.:
82
Cov.:
32
AF XY:
0.0188
AC XY:
1399
AN XY:
74430
show subpopulations
African (AFR)
AF:
0.0647
AC:
2687
AN:
41508
American (AMR)
AF:
0.0127
AC:
194
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00560
AC:
27
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10604
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000323
AC:
22
AN:
68024
Other (OTH)
AF:
0.0180
AC:
38
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
146
292
437
583
729
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
32
64
96
128
160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0106
Hom.:
20
Bravo
AF:
0.0225
Asia WGS
AF:
0.00404
AC:
14
AN:
3478
EpiCase
AF:
0.000218
EpiControl
AF:
0.000474

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link

Submissions by phenotype

PPP1R21-related disorder Benign:1
Mar 25, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.78
CADD
Benign
8.2
DANN
Benign
0.64
PhyloP100
-0.24
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs148229375; hg19: chr2-48681850; API